JACOBIO-B: FORM OF PROXY FOR THE 2024 ANNUAL GENERAL MEETING
Apr 26 05:08 ET
JACOBIO-B: PROPOSED CHANGE OF AUDITOR
Apr 24 10:27 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO PRESENT ED CLINICAL DATA OF PARP7 INHIBITOR JAB-26766 AND P53 REACTIVATOR JAB-30355 AT THE AACR 2024
Apr 9 07:26 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
Apr 3 04:58 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT
Mar 5 05:27 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
Mar 4 03:40 ET
JACOBIO-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 1 03:05 ET
JACOBIO-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 1 02:59 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR P53 Y220C Activator JAB-30300
Feb 29 23:09 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT THE REGISTRATIONAL PHASE III CLINICAL TRIAL OF SHP2 INHIBITOR JAB-3312 IN COMBINATION WITH KRAS G12C INHIBITOR GLECIRASIB APPROVED BY THE CENTER FOR DRUG EVALUATION (CDE) OF THE NMPA
Feb 18 06:50 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
Feb 5 03:42 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTED CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI
Jan 21 05:08 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
Jan 4 03:47 ET
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
Dec 22, 2023 03:38 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO TO PRESENT CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI
Dec 6, 2023 23:00 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023
Dec 4, 2023 03:43 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023
Nov 2, 2023 04:36 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT PRESENTATION OF CLINICAL DATA OF GLECIRASIB IN COMBINATION WITH JAB-3312 AT THE 2023 ESMO CONGRESS
Oct 23, 2023 06:27 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023
Oct 5, 2023 04:33 ET
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
Sep 29, 2023 09:07 ET
No Data
No Data